05:06 PM EDT, 05/01/2024 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) reported Q1 non-GAAP earnings late Wednesday of $0.73 per diluted share, compared with a loss of $0.99 a year earlier.

Analysts polled by Capital IQ expected $0.30.

Revenue for the quarter ended March 31 was $413.5 million, up from $253.5 million a year earlier.

Analysts surveyed by Capital IQ expected $370.5 million.

The company's shares were rising past 5% in recent after-hours activity.

Price: 138.30, Change: +7.40, Percent Change: +5.65